Research demonstrates neurovascular unit dysfunction in ischemic stroke, indicating potential for tailored therapeutic approaches.
NVU dysfunction underlies both acute injury amplification and chronic recovery failure after stroke. Biomarker-guided, phase-specific therapeutic strategies targeting inflammation, oxidative stress, and BBB instability represent a promising framework for personalized stroke management.
No takes yet. Share an insight, caveat, or question.
Lahariya et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: